The potency of an inhalational anesthetic agent depends upon which of the following coefficients?
All of the following are recognized stages of anesthesia except?
In which of the following conditions can ketamine be used?
Which anesthetic agent has the least analgesic property?
Which of the following inhalational agents has the minimum blood-gas solubility coefficient?
Myasthenic patients are resistant to which muscle relaxant?
Stages of anesthesia were described by Guedel with which of the following agents?
Which anesthetic agent does not impair central nervous system activity?
At the end of a balanced anaesthesia technique with a non-depolarizing muscle relaxant, a patient recovered spontaneously from the effect of muscle relaxant without any reversal. Which is the most probable relaxant the patient had received?
Which anesthetic agent has the least minimum alveolar concentration (MAC)?
Explanation: ### Explanation The potency of an inhalational anesthetic is determined by its lipid solubility, which is represented by the **Oil-gas partition coefficient**. #### 1. Why Oil-gas partition coefficient is correct: According to the **Meyer-Overton Hypothesis**, the anesthetic potency of a gas is directly proportional to its lipid solubility. The Oil-gas partition coefficient measures how well a gas dissolves in oil (representing the lipid bilayer of neuronal membranes) compared to air. * **High Oil-gas coefficient = High lipid solubility = High potency.** * Potency is clinically expressed as **MAC (Minimum Alveolar Concentration)**. There is an inverse relationship between the two: **Potency ∝ 1/MAC**. Therefore, an agent with a high oil-gas coefficient will have a low MAC. #### 2. Why other options are incorrect: * **Blood-gas partition coefficient:** This determines the **speed of induction and recovery**, not potency. A lower blood-gas coefficient means the gas is less soluble in blood, leading to faster equilibration with the brain and quicker induction (e.g., Desflurane). * **Gas pressure:** While the partial pressure of a gas drives its movement across gradients, it is a physical property of delivery, not an intrinsic measure of the drug's potency. * **Blood pressure:** This is a physiological parameter of the patient that may be affected by anesthesia (hemodynamic side effects) but does not determine the drug's inherent potency. #### 3. High-Yield Clinical Pearls for NEET-PG: * **Most Potent Agent:** Methoxyflurane (Highest oil-gas coefficient, lowest MAC). * **Least Potent Agent:** Nitrous Oxide (Lowest oil-gas coefficient, highest MAC >100%). * **Speed of Induction:** Determined by Blood-gas solubility (Desflurane is the fastest; Halothane is slow). * **MAC Exceptions:** MAC is highest at 6 months of age and decreases with pregnancy, old age, and acute alcohol ingestion.
Explanation: This question tests your knowledge of **Guedel’s Classification of General Anesthesia**, which historically describes the stages of CNS depression following the administration of an inhalational anesthetic (originally described for diethyl ether). ### **Explanation of the Correct Answer** **B. Allodynia** is the correct answer because it is a clinical symptom of neuropathic pain, defined as pain resulting from a stimulus that does not normally provoke pain (e.g., a light touch). It is not a stage of anesthesia. ### **Analysis of Incorrect Options** Guedel’s stages include: * **Stage I (Analgesia):** Starts from the induction of anesthesia and lasts until the loss of consciousness. The patient remains conscious but feels less pain. * **Stage II (Delirium/Excitement):** Starts from the loss of consciousness to the onset of automatic breathing. This stage is characterized by uninhibited movements, irregular respiration, and potential vomiting/laryngospasm. It is a "danger zone" that clinicians aim to pass through quickly. * **Stage III (Surgical Anesthesia):** Extends from the onset of regular respiration to the cessation of spontaneous breathing. This is the stage where most surgical procedures are performed. It is further divided into four planes based on eye movements and pupillary reflexes. * **Stage IV (Medullary Paralysis):** An overdose stage characterized by respiratory arrest and vasomotor collapse. ### **High-Yield Clinical Pearls for NEET-PG** * **Guedel’s Classification** is most accurately seen with slow-acting agents like **Ether**. Modern intravenous agents (like Propofol) bypass Stages I and II so rapidly that they are rarely observed. * **Stage II Danger:** During Stage II, the airway is highly irritable. Extubation or stimulation during this stage can trigger **laryngospasm**. * **Signs of Stage III:** The hallmark of entering Stage III is the establishment of a regular rhythmic breathing pattern and the loss of the eyelid reflex.
Explanation: **Explanation:** **1. Why Hypovolemia is Correct:** Ketamine is a unique intravenous anesthetic agent that acts as a **sympathomimetic**. It stimulates the sympathetic nervous system, leading to an increase in heart rate, cardiac output, and arterial blood pressure due to the release of endogenous catecholamines. In patients with **hypovolemia** or hemorrhagic shock, these hemodynamic effects help maintain blood pressure and tissue perfusion during induction, making it the induction agent of choice in trauma and emergency settings. **2. Why the Other Options are Incorrect:** * **Myocardial Infarction (MI):** Ketamine increases myocardial oxygen demand due to tachycardia and increased afterload. In a heart already suffering from ischemia (MI), this can worsen the infarct or trigger arrhythmias. * **Hypertension:** Since ketamine directly increases systemic blood pressure, it is contraindicated in patients with uncontrolled hypertension as it may precipitate a hypertensive crisis or cerebrovascular accident. * **Head Injury:** Ketamine is traditionally avoided in head injuries because it is a potent cerebral vasodilator, which can increase cerebral blood flow and **intracranial pressure (ICP)**, potentially worsening brain herniation. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Non-competitive antagonist at **NMDA receptors**. * **Dissociative Anesthesia:** Characterized by eyes remaining open with a slow nystagmic gaze (catalepsy), profound analgesia, and amnesia. * **Airway:** It preserves laryngeal reflexes and is a potent **bronchodilator** (drug of choice for induction in status asthmaticus). * **Side Effects:** Associated with **emergence delirium** and hallucinations (minimized by pre-treatment with benzodiazepines like Midazolam). * **Secretions:** It causes hypersalivation; hence, it is often co-administered with glycopyrrolate.
Explanation: **Explanation:** The core concept in general anesthesia is the distinction between **unconsciousness (hypnosis)** and **pain relief (analgesia)**. While most inhalational agents provide both to varying degrees, their potencies differ significantly. **Why Halothane is the correct answer:** Halothane is a potent hypnotic (high lipid solubility, low MAC) but a very **poor analgesic**. At sub-anesthetic concentrations, it does not provide significant pain relief. In clinical practice, halothane must almost always be supplemented with opioids or nitrous oxide to ensure the patient does not experience autonomic responses to painful surgical stimuli. **Analysis of Incorrect Options:** * **Nitrous Oxide (N₂O):** Known as "laughing gas," it is a **potent analgesic** but a weak anesthetic (MAC of 104%). Even at 20-30% concentration, it provides significant pain relief, making it useful in dentistry and labor. * **Ether:** Diethyl ether is a complete anesthetic. It provides excellent analgesia, muscle relaxation, and unconsciousness. It was historically favored because it maintained spontaneous respiration and blood pressure while providing profound pain relief. * **Propane:** While not used clinically today due to flammability and toxicity, hydrocarbons like propane generally possess higher analgesic properties compared to the specific halogenated structure of halothane. **High-Yield Clinical Pearls for NEET-PG:** * **Analgesic Potency:** Nitrous Oxide > Methoxyflurane > Ether > Halothane (Least). * **Halothane Hepatitis:** A rare but classic side effect caused by the metabolite trifluoroacetylated liver proteins. * **Catecholamine Sensitivity:** Halothane sensitizes the myocardium to adrenaline, increasing the risk of arrhythmias. * **MAC (Minimum Alveolar Concentration):** Remember that MAC is a measure of **potency**, not analgesia. Halothane has a low MAC (0.75%), meaning it is a potent anesthetic but still lacks analgesic efficacy.
Explanation: **Explanation:** The speed of induction and recovery from inhalational anesthesia is primarily determined by the **Blood-Gas Partition Coefficient (λ)**. This value represents the solubility of the anesthetic agent in blood. An agent with **low solubility** (low coefficient) does not dissolve significantly in the blood; therefore, the partial pressure in the alveoli rises rapidly, leading to a faster equilibrium with the brain and a **quicker induction and emergence.** **Why Desflurane is Correct:** Among the options provided, **Desflurane** has the lowest blood-gas solubility coefficient (**0.42**). This makes it the fastest-acting volatile anesthetic, allowing for precise control over the depth of anesthesia and exceptionally rapid recovery, even after prolonged surgery. **Analysis of Incorrect Options:** * **Nitrous Oxide (0.47):** While very insoluble, its coefficient is slightly higher than Desflurane. It is often confused as the "fastest" because of the *Concentration Effect*, but strictly by solubility, Desflurane is lower. * **Sevoflurane (0.65):** A commonly used agent for pediatric mask induction due to its non-pungency, but it is more soluble than Desflurane. * **Isoflurane (1.40):** This is a moderately soluble agent, resulting in significantly slower induction and recovery compared to the newer "fluranes." **High-Yield NEET-PG Pearls:** 1. **Solubility Order (Lowest to Highest):** Desflurane (0.42) < Nitrous Oxide (0.47) < Sevoflurane (0.65) < Isoflurane (1.4) < Halothane (2.4). 2. **Potency vs. Speed:** Potency is determined by **MAC** (Minimum Alveolar Concentration). While Desflurane is the fastest (least soluble), it is the *least potent* volatile agent (MAC ~6%). 3. **Oil-Gas Partition Coefficient:** Correlates with **potency** (Meyer-Overton Hypothesis). Halothane has the highest oil-gas solubility and is the most potent.
Explanation: **Explanation:** In Myasthenia Gravis (MG), there is an autoimmune-mediated destruction of post-synaptic nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction. This reduction in functional receptors significantly alters the patient's response to muscle relaxants. **1. Why Suxamethonium (Succinylcholine) is the correct answer:** Suxamethonium is a **depolarizing** neuromuscular blocker. Because MG patients have fewer functional receptors, they require a higher concentration of the drug to trigger sufficient depolarization to achieve a block. Consequently, they are **resistant** to Suxamethonium, often requiring 2–3 times the normal ED95 dose. **2. Why the other options are incorrect:** * **Pancuronium, Atracurium, and Vecuronium:** These are **non-depolarizing** neuromuscular blockers (NDNMBs). Because MG patients already have a deficit of functional receptors, even a small dose of a competitive antagonist (NDNMB) can easily block the remaining receptors. Therefore, MG patients are **exquisitely sensitive** to these drugs, and doses should be reduced to 1/10th or 1/20th of the standard dose. **High-Yield Clinical Pearls for NEET-PG:** * **The Rule of Opposites:** MG patients are **Resistant** to Depolarizers (Suxamethonium) but **Sensitive** to Non-depolarizers (the "-curoniums"). * **Lambert-Eaton Myasthenic Syndrome (LEMS):** Unlike MG, patients with LEMS are **sensitive to both** depolarizing and non-depolarizing muscle relaxants. * **Post-operative Care:** MG patients are at high risk for post-operative respiratory failure; Sugammadex is preferred over Neostigmine for reversal to avoid "cholinergic crisis." * **Dual Block:** If Suxamethonium is used in MG, it may rapidly transition into a Phase II block.
Explanation: **Explanation:** **Arthur Guedel** described the four stages of anesthesia in 1920, specifically observing the effects of **Diethyl Ether** in unpremedicated patients. Ether was the ideal agent for this classification because it has high blood solubility, leading to a slow and predictable induction. This allowed clinicians to clearly observe the progressive depression of the central nervous system through distinct clinical signs (respiration, eye movements, and pupillary size). **Analysis of Options:** * **Ether (Correct):** Its slow onset and irritant nature made the transition between stages (especially Stage II - Delirium) very prominent and easy to study. * **Chloroform:** While used historically, it was not the agent Guedel used for his landmark classification. It is also more cardiotoxic. * **Nitrous Oxide:** As a "gas," it is an incomplete anesthetic when used alone at atmospheric pressure and cannot easily achieve Stage III (Surgical Anesthesia) without supplemental agents. * **Halothane:** This is a modern volatile anesthetic. Modern agents have faster induction times, making the "Guedel stages" pass so rapidly that they are often clinically indistinguishable. **High-Yield Clinical Pearls for NEET-PG:** 1. **Stage II (Delirium/Excitement):** The most dangerous stage; characterized by irregular breathing and risk of laryngospasm. 2. **Stage III (Surgical Anesthesia):** Divided into 4 planes. Plane 2 is generally ideal for most surgeries. 3. **Modern Practice:** Guedel’s stages are rarely seen today due to the use of rapid-acting IV induction agents (like Propofol) and neuromuscular blockers, which bypass the excitement stage. 4. **Key Sign of Overdose:** Stage IV represents medullary paralysis and impending respiratory/circulatory collapse.
Explanation: **Explanation:** The question focuses on the preservation of **Autoregulation of Cerebral Blood Flow (CBF)**. While most general anesthetics depress the Central Nervous System (CNS) and alter cerebral hemodynamics, **Isoflurane** is unique among the potent volatile agents for its favorable profile regarding CNS activity and metabolic demand. **1. Why Isoflurane is the Correct Answer:** At concentrations up to 1 MAC (Minimum Alveolar Concentration), Isoflurane produces a dose-dependent decrease in **Cerebral Metabolic Rate of Oxygen (CMRO2)**. This reduction in metabolic demand is so significant that it offsets the drug’s inherent vasodilatory effects. Consequently, at clinical doses, Isoflurane **preserves cerebral autoregulation** better than other volatile agents, meaning it does not "impair" the brain's natural ability to match blood flow with metabolic need. It is often considered the volatile agent of choice for neurosurgery. **2. Why the Other Options are Incorrect:** * **Enflurane:** It is known to increase CSF production and, more importantly, can induce **seizure-like activity** (epileptiform EEG patterns), especially under conditions of hypocapnia. This represents an impairment/alteration of normal CNS electrical activity. * **Desflurane:** Like Sevoflurane, at higher concentrations (>1 MAC), Desflurane causes significant cerebral vasodilation and can impair autoregulation, leading to an increase in Intracranial Pressure (ICP). * **Ketamine:** A "dissociative" anesthetic that actually **increases CMRO2, CBF, and ICP**. It stimulates the CNS (sympathomimetic effect) rather than depressing it in a traditional sense, making it contraindicated in patients with intracranial space-occupying lesions. **High-Yield Clinical Pearls for NEET-PG:** * **Neuroprotection:** Isoflurane provides the greatest reduction in CMRO2 among volatiles (up to 50% reduction), leading to an "isoelectric EEG." * **Drug of Choice:** For neurosurgery, Isoflurane is preferred; however, **Thiopental** remains the gold standard for "brain protection" during focal ischemia. * **Avoid in Epilepsy:** Enflurane and Ketamine should be avoided in patients with a history of seizures.
Explanation: **Explanation:** The correct answer is **Atracurium** because of its unique metabolism, which allows for predictable recovery independent of organ function or pharmacological reversal. **Why Atracurium is correct:** Atracurium (and its isomer Cisatracurium) undergoes **Hofmann Elimination**—a non-enzymatic, spontaneous degradation that occurs at physiological pH and temperature. It also undergoes ester hydrolysis by non-specific plasma esterases. Because it does not rely on the liver for metabolism or the kidneys for excretion, the drug clears from the plasma rapidly and spontaneously. This makes it the "drug of choice" in patients with renal or hepatic failure and explains why a patient can recover fully without the need for a reversal agent like Neostigmine. **Why the other options are incorrect:** * **Pancuronium:** A long-acting muscle relaxant primarily excreted by the kidneys (80%). It has a high potential for cumulative effects and residual neuromuscular blockade, making spontaneous recovery without reversal unlikely and risky. * **Gallamine:** A long-acting relaxant excreted almost entirely (95-100%) unchanged in the urine. It is contraindicated in renal failure and strictly requires reversal. * **Vecuronium:** An intermediate-acting relaxant metabolized primarily by the liver and excreted in bile. While shorter-acting than Pancuronium, it still relies on organ clearance and typically requires reversal to ensure a safe Train-of-Four (TOF) ratio. **High-Yield Clinical Pearls for NEET-PG:** * **Hofmann Elimination** is temperature and pH-dependent; it is slowed by hypothermia and acidosis. * **Laudanosine:** A metabolite of Atracurium that can cross the blood-brain barrier and may cause seizures (though rare in clinical doses). * **Cisatracurium** is more potent than Atracurium and produces significantly less laudanosine and histamine release. * **Drug of Choice in Renal/Hepatic Failure:** Atracurium or Cisatracurium.
Explanation: ### Explanation **Concept: MAC and Potency** The **Minimum Alveolar Concentration (MAC)** is the concentration of an inhaled anesthetic at 1 atmosphere that prevents skeletal muscle movement in response to a noxious stimulus (surgical incision) in 50% of patients. MAC is **inversely proportional** to the potency of an anesthetic agent. Therefore, the agent with the **lowest MAC value is the most potent.** **Why Isoflurane is Correct:** Among the options provided, **Isoflurane** has the lowest MAC value, making it the most potent agent in this list. * **Isoflurane MAC:** ~1.15% **Analysis of Incorrect Options:** * **Nitrous Oxide (A):** Has the highest MAC (~104%), making it the least potent. It cannot produce surgical anesthesia alone at atmospheric pressure. * **Desflurane (C):** Has a MAC of ~6.0%. While it is fast-acting due to low blood-gas solubility, it is significantly less potent than Isoflurane. * **Xenon (D):** An inert gas with a MAC of ~63–71%. It is more potent than Nitrous Oxide but much less potent than volatile liquids like Isoflurane. **High-Yield NEET-PG Pearls:** 1. **Potency Ranking (Lowest MAC to Highest):** Halothane (0.75%) > Isoflurane (1.15%) > Sevoflurane (2.0%) > Desflurane (6.0%) > Xenon (71%) > Nitrous Oxide (104%). 2. **Meyer-Overton Hypothesis:** States that anesthetic potency correlates directly with lipid solubility (Oil:Gas partition coefficient). 3. **Factors Increasing MAC (Requiring more drug):** Hyperthermia, chronic alcohol abuse, hypernatremia, and increased central neurotransmitters (e.g., cocaine use, MAO inhibitors). 4. **Factors Decreasing MAC (Requiring less drug):** Pregnancy, old age, acute alcohol intoxication, hypothermia, and anemia.
History of Anesthesia
Practice Questions
Preoperative Evaluation
Practice Questions
Pharmacology of Inhalational Anesthetics
Practice Questions
Pharmacology of Intravenous Anesthetics
Practice Questions
Neuromuscular Blocking Agents
Practice Questions
Airway Management
Practice Questions
Endotracheal Intubation
Practice Questions
Difficult Airway Algorithms
Practice Questions
Intraoperative Monitoring
Practice Questions
Depth of Anesthesia Monitoring
Practice Questions
Emergence from Anesthesia
Practice Questions
Postoperative Care
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free